ask="7.20"
ask_size="1200"
average_daily_volume="44219"
bid="0.97"
bid_size="200"
book_value="0.81"
change="-0.03"
change_from_200_day_moving_average="-0.48"
change_from_50_day_moving_average="-0.12"
change_from_52_week_high="-2.49"
change_From_52_week_low="0.23"
change_in_percent="-2.36%"
close="1.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-6.98M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2446000"
high="1.53"
high_52_weeks="3.94"
last_trade_date="1/9/2017"
last_trade_price="1.45"
last_trade_size="300"
last_trade_time="3:57pm"
low="1.40"
low_52_weeks="1.22"
market_capitalization="15.93M"
moving_average_200_day="1.93"
moving_average_50_day="1.57"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.51"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-24.79%"
percent_change_from_50_day_moving_average="-7.86%"
percent_change_from_52_week_high="-63.20%"
percent_change_from_52_week_low="+18.85%"
previous_close="1.49"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.83"
price_per_sales="4.30"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.62"
stock_exchange="NCM"
symbol="CBLI"
volume="12739"
weeks_range_52="1.22 - 3.94"
